UNSPSC 51161529: Acreozast

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51161529

Definition

This classification denotes an anti-asthmatic agent with the molecular formula C15H14ClN3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 84DZ9RW4WK, chemically known as 3,5-bis(acetoxyacetylamino)-4-chlorobenzonitrile but generally known as acreozast, which bears US NIH Compound Identifier 129991. European Medicines Agency schedules Acreozast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05248MIG.

Read the full definition

The term ACREOZAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 1 1998, List 39). ACREOZAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule acreozast under HS 29269095 and SITC 51484. As of Q4 2014, ACREOZAST remains the US FDA Preferred Term for this commodity. Acreozast bears US NLM identifiers UMLS ID C2347176 and NCI Concept Code C74131. SMILES: CLC1C(NC(=O)COC(=O)C)CC(CC1NC(=O)COC(=O)C)C#N.

About UNSPSC 51161529

UNSPSC 51161529 Acreozast, a Commodity code, covers generic multi-source pharmaceuticals and over-the-counter products that state and local government health systems, hospitals, and facilities procure through cooperative purchasing agreements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the primary issuing body soliciting under this code, using cooperative contracting vehicles to aggregate demand across participating state agencies, local government facilities, and member jurisdictions including Oregon. Vendors supply products through authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) and must certify compliance with current Good Manufacturing Practices (cGMP), the Drug Supply Chain Security Act (DSCSA), and FDA requirements. Evaluation criteria emphasize price competitiveness (75 percent weight), with secondary factors including fixed pricing structure, administrative fee compliance, EDI capability, and contractual relationships with at least two of the three authorized wholesalers.

MMCAP's January 2026 Request for Proposal for Generic Multi Source Pharmaceuticals and OTC Products (S1070000015802, due March 26, 2026) represents the most recent activity under this code. The procurement establishes multiple contracts effective July 1, 2026, for a two-year term with optional extensions, and requires vendors to submit pricing in flat-price, net-price (NF30, NF60, NF90), or WAC-minus formats along with detailed product information including NDC codes, SKUs, UPCs, and manufacturing locations. Vendors must maintain comprehensive insurance including $5,000,000 commercial general liability, $2,000,000 network security and privacy liability, and $2,000,000 professional liability, and face performance penalties of $200 to $1,500 per violation for late reporting or missed onboarding timelines. The RFP does not identify specific set-aside designations or budget ranges.

Quick answers

What is UNSPSC 51161529?

UNSPSC 51161529 is Acreozast, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51161529?

UNSPSC 51161529 maps to 1 NIGP code, 26973 Muscle Relaxants, Smooth (Including Respiratory Drugs).

On GovTribe

See everything under UNSPSC 51161529

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code